Central Nervous System Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery

Oct 2021| TBR333E| TBRC (Publisher)

Report Highlights

Including: 1) By Type: Multiple Sclerosis (MS); Anti-Psychotic; Analgesics; Anti-Parkinson Drugs; Anesthetics; Anti-Epileptics; Anti-Depressants; Other CNS Drugs
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
3) By Route Of Administration: Oral; Intravenous; Intranasal/ Inhalation; Others
4) By Drug Classification: Branded Drugs; Generic Drugs
5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs
Covering: Biogen Inc.; Johnson & Johnson; Hoffmann-La Roche Ltd; Novartis AG; UCB

Central Nervous System Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global central nervous system drugs market as it emerges from the COVID 19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 48 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis

Description:
Where is the largest and fastest growing market for central nervous system drugs? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The central nervous system drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider central nervous system drugs market; and compares it with other markets.

The report covers the following chapters

  • Executive Summary – The executive summary section of the report gives a brief overview and summary of the report
  • Report Structure – This section gives the structure of the report and the information covered in the various sections.
  • Introduction – The introduction section of the report gives brief introduction about segmentation by geography, segmentation by type, and segmentation by medication.
  • Market Characteristics – The market characteristics section of the report defines and explains the central nervous system drugs market. This chapter also defines and describes goods and related services covered in the report.
  • Trends And Strategies – This chapter describes the major trends shaping the global central nervous system drugs market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
  • Impact of COVID-19 – This section describes the impact of COVID-19 on the central nervous system drugs market.
  • Global Market Size And Growth – This section contains the global historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional Analysis – This section contains the historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values and growth and market share comparison by region.
  • Market Segmentation – This section contains the market values (2015-2030) and analysis for different segments.
  • Regional Market Size and Growth – This section contains the region’s market size (2020), historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.
  • Competitive Landscape – This section covers details on the competitive landscape of the global central nervous system drugs market, estimated market shares and company profiles for the leading players.
  • Key Mergers And Acquisitions – This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies– This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
  • Conclusions And Recommendations – This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for central nervous system drugs in terms of services offerings, geographic expansion, marketing strategies and target groups.
  • Appendix – This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

 

 

Scope

Markets Covered:

  • By Type: Multiple Sclerosis (MS); Anti-Psychotic; Analgesics; Anti-Parkinson Drugs; Anesthetics; Anti-Epileptics; Anti-Depressants; Other CNS Drugs
  • By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
  • By Route Of Administration: Oral; Intravenous; Intranasal/ Inhalation; Others
  • By Drug Classification: Branded Drugs; Generic Drugs
  • By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs

Companies Mentioned: Biogen Inc.; Johnson & Johnson; Hoffmann-La Roche Ltd; Novartis AG; UCB

Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; central nervous system drugs indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

  • Table 1 : Global Central Nervous System Drugs Market, Product Analysis – Product Examples
  • Table 2 : Global Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 3 : Global Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 4 : Global Central Nervous System Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 5 : Global Central Nervous System Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 6 : Global Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, Split By Region
  • Table 7 : Global Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Region
  • Table 8 : Global Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 9 : Global Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 10 : Global Central Nervous System Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 11 : Global Central Nervous System Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 12 : Global Central Nervous System Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 13 : Global Central Nervous System Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 14 : Global Central Nervous System Drugs Market, Segmentation By Drug Classification, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 15 : Global Central Nervous System Drugs Market, Segmentation By Drug Classification, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 16 : Global Central Nervous System Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 17 : Global Central Nervous System Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 18 : Global Central Nervous System Drugs Market Value, Market Size As A Percentage Of Global GDP, 2015 – 2025
  • Table 19 : Global Central Nervous System Drugs Market, Per Capita Average Central Nervous System Drugs Market Industry Expenditure, 2015 – 2025, ($)
  • Table 20 : Asia-Pacific Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 21 : Asia-Pacific Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 22 : Asia-Pacific Per Capita Net Disposable Income, 2015-2019, $
  • Table 23 : Asia Pacific Population By Age Group, 2015-2023, Thousands
  • Table 24 : Asia-Pacific Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 25 : Asia-Pacific Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 26 : Asia-Pacific Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 27 : Asia-Pacific Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 28 : Asia-Pacific Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)
  • Table 29 : Asia-Pacific Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
  • Table 30 : Asia-Pacific Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
  • Table 31 : Asia-Pacific Per Capita Central Nervous System Drugs Expenditure, By Country, 2020, $
  • Table 32 : Australia Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 33 : Australia Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 34 : Australia Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 35 : Australia Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 36 : China Pharmaceuticals, 2015-2020, $ Billion
  • Table 37 : China Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 38 : China Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 39 : China Per Capita Net Disposable Income, 2015-2019, $
  • Table 40 : China Population By Age Group, 2015-2023, Thousands
  • Table 41 : China Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 42 : China Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 43 : China Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 44 : China Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 45 : Hong Kong Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 46 : Hong Kong Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 47 : India Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 48 : India Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 49 : India Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 50 : India Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 51 : Indonesia Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 52 : Indonesia Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 53 : Indonesia Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 54 : Indonesia Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 55 : Japan Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 56 : Japan Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 57 : Japan Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 58 : Japan Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 59 : Malaysia Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 60 : Malaysia Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 61 : New Zealand Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 62 : New Zealand Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 63 : Philippines Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 64 : Philippines Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 65 : Singapore Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 66 : Singapore Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 67 : South Korea Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 68 : South Korea Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 69 : South Korea Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 70 : South Korea Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 71 : Thailand Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 72 : Thailand Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 73 : Vietnam Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 74 : Vietnam Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 75 : Western Europe Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 76 : Western Europe Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 77 : Western Europe Per Capita Net Disposable Income, 2015-2019, $
  • Table 78 : Western Europe Population By Age Group, 2015-2023, Thousands
  • Table 79 : Western Europe Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 80 : Western Europe Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 81 : Western Europe Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 82 : Western Europe Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 83 : Western Europe Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)
  • Table 84 : Western Europe Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
  • Table 85 : Western Europe Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
  • Table 86 : Western Europe Per Capita Central Nervous System Drugs Expenditure, By Country, 2020, $
  • Table 87 : Austria Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 88 : Austria Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 89 : Belgium Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 90 : Belgium Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 91 : Denmark Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 92 : Denmark Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 93 : Finland Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 94 : Finland Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 95 : France Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 96 : France Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 97 : France Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 98 : France Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 99 : Germany Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 100 : Germany Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 101 : Germany Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 102 : Germany Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 103 : Ireland Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 104 : Ireland Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 105 : Italy Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 106 : Italy Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 107 : Netherlands Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 108 : Netherlands Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 109 : Norway Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 110 : Norway Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 111 : Portugal Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 112 : Portugal Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 113 : Spain Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 114 : Spain Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 115 : Sweden Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 116 : Sweden Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 117 : Switzerland Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 118 : Switzerland Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 119 : UK Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 120 : UK Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 121 : UK Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 122 : UK Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 123 : Eastern Europe Public Healthcare Expenditure, 2015-2019,$Billion
  • Table 124 : Eastern Europe Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 125 : Eastern Europe Per Capita Net Disposable Income, 2015-2019, $
  • Table 126 : Eastern Europe Population By Age Group, 2015-2023, Thousands
  • Table 127 : Eastern Europe Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 128 : Eastern Europe Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 129 : Eastern Europe Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 130 : Eastern Europe Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 131 : Eastern Europe Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)
  • Table 132 : Eastern Europe Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
  • Table 133 : Eastern Europe Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
  • Table 134 : Eastern Europe Per Capita Central Nervous System Drugs Expenditure, By Country, 2020, $
  • Table 135 : Czech Republic Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 136 : Czech Republic Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 137 : Poland Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 138 : Poland Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 139 : Romania Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 140 : Romania Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 141 : Russia Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 142 : Russia Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 143 : Russia Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 144 : Russia Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 145 : North America Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 146 : North America Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 147 : North America Per Capita Net Disposable Income, 2015-2019, $
  • Table 148 : North America Population By Age Group, 2015-2023, Thousands
  • Table 149 : North America Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 150 : North America Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 151 : North America Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 152 : North America Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 153 : North America Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)
  • Table 154 : North America Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
  • Table 155 : North America Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
  • Table 156 : North America Per Capita Central Nervous System Drugs Expenditure, By Country, 2020, $
  • Table 157 : Canada Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 158 : Canada Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 159 : Mexico Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 160 : Mexico Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 161 : USA Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 162 : USA Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 163 : USA Per Capita Net Disposable Income, 2015-2019, $
  • Table 164 : USA Market, Population By Age Group, 2015-2023, Thousands
  • Table 165 : USA Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 166 : USA Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 167 : USA Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 168 : USA Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 169 : South America Public Healthcare Expenditure, 2015-2019, $ Billion
  • Table 170 : South America Private Healthcare Expenditure, 2015-2019, $ Billion
  • Table 171 : South America Per Capita Net Disposable Income, 2015-2019, $
  • Table 172 : South America Population By Age Group, 2015-2023, Thousands
  • Table 173 : South America Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Table 174 : South America Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 175 : South America Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 176 : South America Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 177 : South America Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)
  • Table 178 : South America Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
  • Table 179 : South America Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
  • Table 180 : South America Per Capita Central Nervous System Drugs Expenditure, By Country, 2020, $
  • Figure 1 : Global Central Nervous System Drugs Market Segmentation By Type
  • Figure 2 : Global Central Nervous System Drugs Market Segmentation By Distribution Channel
  • Figure 3 : Global Central Nervous System Drugs Market Segmentation By Route Of Administration
  • Figure 4 : Global Central Nervous System Drugs Market Segmentation By Drug Classification
  • Figure 5 : Global Central Nervous System Drugs Market Segmentation By Mode Of Purchase
  • Figure 6 : Market Supply Chain For Central Nervous System Drugs
  • Figure 7 : Global Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 8 : Global Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 9 : Global Central Nervous System Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 10 : Global Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, Split By Region
  • Figure 11 : Global Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Region
  • Figure 12 : Global Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 13 : Global Central Nervous System Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 14 : Global Central Nervous System Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 15 : Global Central Nervous System Drugs Market, Segmentation By Drug Classification, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 16 : Global Central Nervous System Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 17 : Asia-Pacific Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 18 : Asia-Pacific Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 19 : Asia-Pacific Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 20 : Asia-Pacific Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)
  • Figure 21 : Asia-Pacific Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
  • Figure 22 : Asia-Pacific Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
  • Figure 23 : Australia Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 24 : Australia Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 25 : Australia Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 26 : China Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 27 : China Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 28 : China Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 29 : Hong Kong Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 30 : Hong Kong Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 31 : India Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 32 : India Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 33 : India Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 34 : Indonesia Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 35 : Indonesia Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 36 : Indonesia Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 37 : Japan Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 38 : Japan Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 39 : Japan Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 40 : Malaysia Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 41 : Malaysia Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 42 : New Zealand Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 43 : New Zealand Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 44 : Philippines Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 45 : Philippines Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 46 : Singapore Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 47 : Singapore Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 48 : South Korea Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 49 : South Korea Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 50 : South Korea Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 51 : Thailand Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 52 : Thailand Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 53 : Vietnam Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 54 : Vietnam Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 55 : Western Europe Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 56 : Western Europe Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 57 : Western Europe Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 58 : Western Europe Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)
  • Figure 59 : Western Europe Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
  • Figure 60 : Western Europe Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
  • Figure 61 : Austria Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 62 : Austria Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 63 : Belgium Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 64 : Belgium Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 65 : Denmark Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 66 : Denmark Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 67 : Finland Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 68 : Finland Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 69 : France Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 70 : France Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 71 : France Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 72 : Germany Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 73 : Germany Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 74 : Germany Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 75 : Ireland Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 76 : Ireland Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 77 : Italy Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 78 : Italy Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 79 : Netherlands Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 80 : Netherlands Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 81 : Norway Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 82 : Norway Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 83 : Portugal Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 84 : Portugal Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 85 : Spain Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 86 : Spain Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 87 : Sweden Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 88 : Sweden Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 89 : Switzerland Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 90 : Switzerland Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 91 : UK Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 92 : UK Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 93 : UK Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 94 : Eastern Europe Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 95 : Eastern Europe Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 96 : Eastern Europe Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 97 : Eastern Europe Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)
  • Figure 98 : Eastern Europe Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
  • Figure 99 : Eastern Europe Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
  • Figure 100 : Czech Republic Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 101 : Czech Republic Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 102 : Poland Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 103 : Poland Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 104 : Romania Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 105 : Romania Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 106 : Russia Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 107 : Russia Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 108 : Russia Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 109 : North America Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 110 : North America Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 111 : North America Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 112 : North America Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)
  • Figure 113 : North America Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
  • Figure 114 : North America Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
  • Figure 115 : Canada Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 116 : Canada Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 117 : Mexico Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 118 : Mexico Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 119 : USA Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 120 : USA Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 121 : USA Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 122 : South America Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 123 : South America Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 124 : South America Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 125 : South America Central Nervous System Drugs Market, 2020, By Country, Value ($ Million)
  • Figure 126 : South America Central Nervous System Drugs Market, 2015 – 2025, Historic And Forecast Growth Rate, By Country
  • Figure 127 : South America Central Nervous System Drugs Market, 2020 – 2025, Growth And Market Share Comparison, By Country
  • Figure 128 : Argentina Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 129 : Argentina Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 130 : Brazil Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 131 : Brazil Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 132 : Brazil Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 133 : Chile Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 134 : Chile Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 135 : Colombia Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 136 : Colombia Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 137 : Peru Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 138 : Peru Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 139 : Venezuela Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million
  • Figure 140 : Venezuela Central Nervous System Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 141 : Middle East Central Nervous System Drugs Market, Historic, 2015 – 2020, $ Million

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS
Share This Report